The American College of Radiology® (ACR®) created a detailed summary of the federal fiscal year 2024 Inpatient Prospective Payment System (IPPS) and long-term care hospital prospective payment system (LTCH PPS) proposed rule released by The Centers for Medicare and Medicaid Services (CMS) April 10. The summary outlines proposed payment and program changes that impact radiology under this payment system.
An important highlight of the ACR summary is the proposed changes to the New Technology Add-on Payment (NTAP) program and application process. An NTAP designation enables additional payment to hospitals above the standard Medicare Severity Diagnosis-Related Group (MS-DRG) payment amount. For FY2024, CMS is proposing to require NTAP applicants for technologies that are not already FDA market authorized to have a complete and active FDA market authorization application request at the time of submission of NTAP application submission. CMS is also proposing to move the FDA approval deadline from July 1 to May 1, beginning with applications for FY 2025. CMS believes these policy changes would improve the completeness of submitted NTAP applications and would allow CMS to identify eligibility concerns for the proposed rule. CMS is proposing to continue NTAP payments for 11 technologies that will remain eligible in FY 2024 which will receive $131 million in reimbursement for FY2024.